We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A new report from SACN concludes that a lower carbohydrate diet is an effective short-term option for adults living with type 2 diabetes and overweight or obesity.
Diabetic ketoacidosis has been reported in patients with type 2 diabetes on a combination of a GLP-1 receptor agonist and insulin who had doses of concomitant insulin rapidly reduced or discontinued. GLP-1 receptor agonists are not substitutes for insulin, and...
People with diabetes using a particular type of insulin pump and pre-filled insulin cartridges should insert their cartridges correctly to avoid them leaking and potentially giving an under-delivery of insulin.
False blood glucose readings when used to flush arterial lines leading to incorrect insulin administration and potentially fatal hypoglycaemia.
Cutaneous amyloidosis at the injection site has been reported in patients using insulin and this may affect glycaemic control. Remind patients to rotate injection sites within the same body region.
The authorisation holder for dapagliflozin has withdrawn the indication for type 1 diabetes mellitus. The removal of the type 1 diabetes indication is not due to any new safety concerns and the other indications of dapagliflozin are unchanged.
Drivers who treat their diabetes with insulin will have greater choice in how they test their glucose levels under new guidelines published today by the DVLA.
Employment Tribunal decision.
Innovate UK-supported life science company Phynova finds further evidence that its plant-based food ingredient promotes healthy blood sugar.
Patients who use products that contain maltose, xylose, or galactose should use glucose-specific monitors.
The Scientific Advisory Committee on Nutrition (SACN) has today published a consultation on its draft report on lower carbohydrate diets for people with type 2 diabetes.
SGLT2 inhibitor treatment should be interrupted in patients who are hospitalised for major surgical procedures or acute serious medical illnesses and ketone levels measured, preferably in blood rather than urine. Treatment may be restarted when the ketone values are normal...
People with diabetes who use particular blood glucose test strips should stop using them and seek an alternative as soon as possible says the Medicines and Healthcare products Regulatory Agency (MHRA). This follows a manufacturing fault which could lead to...
Monitor glucose levels closely in patients with diabetes during direct-acting antiviral therapy for hepatitis C, particularly within the first 3 months of treatment, and modify diabetes medication or doses when necessary. Patients with diabetes may experience symptomatic hypoglycaemia if diabetic...
Users of this continuous glucose monitoring system may experience adverse skin reactions to the sensor.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).